Log in
Enquire now
‌

US Patent 11858980 Engineered polypeptides and uses thereof

Patent 11858980 was granted and assigned to Visterra Inc. on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Visterra Inc.
0
Date Filed
August 2, 2017
0
Date of Patent
January 2, 2024
0
Patent Applicant
‌
Visterra Inc.
0
Patent Application Number
15667309
0
Patent Citations
‌
US Patent 7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same
0
‌
US Patent 7371826 Polypeptide variants with altered effector function
0
‌
US Patent 7416727 Polypeptide variants with altered effector function
0
‌
US Patent 7658921 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7670600 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7704497 Molecules with extended half-lives, compositions and uses thereof
0
‌
US Patent 7785791 Polypeptide variants with altered effector function
0
‌
US Patent 7790858 Polypeptide variants with altered effector function
0
‌
US Patent 8003774 Identification and engineering of antibodies with variant Fc regions and methods of using same
0
‌
US Patent 8012476 Molecules with extended half-lives, compositions and uses thereof
0
•••
Patent Inventor Names
Brian Booth
0
Boopathy Ramakrishnan
0
Andrew M. Wollacott
0
Kristin Narayan
0
Karthik Viswanathan
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11858980
0
Patent Primary Examiner
‌
Chun W Dahle
0

Find more entities like US Patent 11858980 Engineered polypeptides and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.